Data & Analytics: New Frontiers for Big Data
Journal Ad Review: Paper Chase
Therapeutic Focus 2014: Metabolic
Specialty Pharma: Coverage at the Crossroads
MAHF 2014: Honoring Our Heroes
MM&M Awards: How to Win
Private View: Telling good brand stories
Read the complete 2014 MM&M Digital Guide digital edition
A report of over 270,000 US medical sites signals that EHR adoption is no longer a luxury reserved for hospitals and health systems.
The FDA's bad-ad unit took a drugmaker to task for what it calls a misleading Facebook page. History shows the social media surveillance should take no one by surprise.
Pfizer hit its endpoints for preventing pneumonia among the elderly, but the data may not be robust enough to spur vaccination.
Express Scripts notes that these prescriptions may not, in fact, be for ADHD.
Healthcare companies are partnering with social entrepreneurs to drive their own agendas on affordability and access while staying at the forefront of global initiatives
Around 25% of 18-34 year-olds have signed up for coverage. Obama's FunnyorDie appearance drives HHS traffic.
The drugmaker's outreach efforts involve switching patients to the latest—and patented—Copaxone formulation.
Draft guidance indicates the regulator is open to using patient experience as criteria for chronic fatigue syndrome treatments.
Click on the image above to see a gallery of images from the 2013 MM&M Awards dinner
The new MM&M e-book, "Oncology Marketing," is designed to serve as a companion for those in the business of communicating cancer products to all three stakeholders. It's packed with analysis, advice, insights and commentary to help navigate the terrain. Click here to access it.